SLNO
SLNO
NASDAQ · Biotechnology

Soleno Therapeutics Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$53.01
+0.00 (+0.00%)
As of Nov 7, 1:40 AM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 0 0%
Hold 13 81%
Sell 3 19%
Price Target
Analyst Price Target -62.4% upside
Low Target $16.99
Average Target $19.95
High Target $27.29
Current Price $53.01
Current
$53.01
Target
$19.95
$16.99 $19.95 avg $27.29
Scenario Analysis
Bear Case
$16.99
-67.9%
Low target
Base Case
$19.95
-62.4%
Avg target
Bull Case
$27.29
+-48.5%
High target
Risk/Reward
0.7x
Unfavorable
Price in Context
52-Week High
$69.99
-24.3% from high
52-Week Low
$29.43
+80.1% from low
50-Day SMA
$45.79
+15.8% vs SMA
200-Day SMA
$52.40
+1.2% vs SMA
RSI (14)
93.1
Overbought
Target vs 52W High
$19.95
-71.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 39 82% $257.58 -11.6%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.5%
GILD
Gilead Sciences Inc
 Strong Buy 37 81% $362.68 +117.3%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -19.9%
MRNA
Moderna Inc
 Hold 31 35% $149.45 -41.2%
REGN
Regeneron Pharmaceuticals
 Buy 37 70% $76.80 -91.5%
NTRA
Natera Inc
 Strong Buy 30 90% $142.91 -54.0%
RVMD
Revolution Medicines Inc
 Strong Buy 29 93% $114.11 -40.7%